0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Pain
 201-220 of 262 Articles
Original Investigation |  FREE
Peter A. McCullough, MD, MPH; Richard M. Nowak, MD, MBA; Craig Foreback, PhD; et al.
Arch Intern Med. 2002;162(21):2464-2468. doi:10.1001/archinte.162.21.2464.

Editor's Correspondence | 
Richard R. P. Warner, MD
Arch Intern Med. 2002;162(14):1647-1648. doi:.

Controversies in Internal Medicine | 
Irwin Abraham, MD
Arch Intern Med. 2002;162(13):1447. doi:10.1001/archinte.162.13.1447.

Controversies in Internal Medicine | 
Irwin Abraham, MD; Brenda Killackey-Jones, MS
Arch Intern Med. 2002;162(13):1442-1444. doi:10.1001/archinte.162.13.1442.

Original Investigation |  FREE
Leif Friberg, MD; Sigbritt Werner, MD, PhD; Gösta Eggertsen, MD, PhD; et al.
Arch Intern Med. 2002;162(12):1388-1394. doi:10.1001/archinte.162.12.1388.

Editor's Correspondence | 
Louis C. Johnston, MD
Arch Intern Med. 2002;162(11):1310-1311. doi:.

Editor's Correspondence | 
Stephen M. Salerno, MD, MPH; Jeffrey L. Jackson, MD, MPH
Arch Intern Med. 2002;162(11):1310-1311. doi:.

Original Investigation |  FREE
Christine Knottenbelt, MB, ChB; Patrick J. Brennan, MSc; Tom W. Meade, DM, FRS; et al.
Arch Intern Med. 2002;162(8):881-886. doi:10.1001/archinte.162.8.881.

Original Investigation |  FREE
Kate R. Lorig, DrPH; Diana D. Laurent, MPH; Richard A. Deyo, MD; et al.
Arch Intern Med. 2002;162(7):792-796. doi:10.1001/archinte.162.7.792.

Editor's Correspondence | 
J. Borja, MD; M. A. Paz, MD; P. Olivella, MD
Arch Intern Med. 2002;162(4):485-486. doi:.

Editor's Correspondence | 
Robert A. O'Rourke, MD
Arch Intern Med. 2002;162(4):485-486. doi:.

Editor's Correspondence | 
Yehuda Ringel, MD; Nicholas J. Shaheen, MD; Douglas A. Drossman, MD
Arch Intern Med. 2002;162(3):365. doi:.

Editor's Correspondence | 
Leonard Schwartz, MD; Martial G. Bourassa, MD
Arch Intern Med. 2002;162(3):366. doi:.

Original Investigation |  FREE
Robert John Petrella, MD, PhD; Mathew Dennis DiSilvestro, MSc; Catherine Hildebrand, PhD
Arch Intern Med. 2002;162(3):292-298. doi:10.1001/archinte.162.3.292.

Comments, Opinions, and Brief Case Reports | 
Spalato Signorelli, MD; Stefano Tolomelli, MD; Edda Rota, MD; et al.
Arch Intern Med. 2002;162(1):95. doi:.

Review Article |  FREE
Stephen M. Salerno, MD, MPH; Robert Browning, MD; Jeffrey L. Jackson, MD, MPH
Arch Intern Med. 2002;162(1):19-24. doi:10.1001/archinte.162.1.19.

Original Investigation |  FREE
Francesco Landi, MD, PhD; Graziano Onder, MD; Matteo Cesari, MD; et al.
Arch Intern Med. 2001;161(22):2721-2724. doi:10.1001/archinte.161.22.2721.

Editor's Correspondence | 
Amit K. Ghosh, MD
Arch Intern Med. 2001;161(20):2507. doi:.

Editor's Correspondence | 
Christoph A. Nienaber, MD
Arch Intern Med. 2001;161(20):2507. doi:.

Original Investigation |  FREE
Morris Maizels, MD
Arch Intern Med. 2001;161(16):1969-1973. doi:10.1001/archinte.161.16.1969.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Surgery
JAMA Surgery Clinical Challenge  | 
Child With Abdominal Pain and a Cystic Pelvic Mass
Matthew M. Boelig, MD; Pablo Laje, MD; William H. Peranteau, MD
JAMA Neurology
Editorial  | 
Targeting the Interleukin 6 Receptor to Treat Neuromyelitis Optica
Sarosh R. Irani, MD, DPhil; Angela Vincent, FRCPath
JAMA Neurology
Original Investigation  | 
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
Marius Ringelstein, MD; Ilya Ayzenberg, MD; Jens Harmel, MD; et al.
JAMA Dermatology
Research Letter  | 
Topically Applied Midodrine, 0.2%, an α1-Agonist, for the Treatment of Erythromelalgia
Mark D. P. Davis, MD; Claudia S. Morr, MD; Roger A. Warndahl, BS Pharm; et al.